HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 29.80
Day range
kr 28.00 - kr 31.00
Year range
kr 22.10 - kr 85.92
Market cap
213.18M SEK
Avg Volume
9.38K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
UPS
4.03%
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.41M | -41.28% |
Net income | -8.50M | 41.42% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.36M | 41.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 46.26M | 23.84% |
Total assets | 49.09M | 18.56% |
Total liabilities | 3.74M | -30.27% |
Total equity | 45.35M | — |
Shares outstanding | 7.06M | — |
Price to book | 4.64 | — |
Return on assets | -43.29% | — |
Return on capital | -47.65% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -8.50M | 41.42% |
Cash from operations | -9.94M | 32.48% |
Cash from investing | — | — |
Cash from financing | 10.97M | -75.19% |
Net change in cash | 1.03M | -96.51% |
Free cash flow | -6.74M | 27.03% |
About
Founded
2014
Website
Employees
4